P58.5 Neonatal jaundice due to swallowed maternal blood

Name of the Condition

• Neonatal jaundice due to swallowed maternal blood
• ICD-10-CM Code: P58.5

Summary

This condition describes jaundice in a newborn resulting from increased bilirubin levels caused by the ingestion of maternal blood. It occurs when red blood cells from swallowed maternal blood break down, releasing bilirubin that the newborn's immature liver cannot process efficiently, leading to visible yellowing of the skin and eyes.

Causes

Swallowed maternal blood, typically from sources like maternal vaginal bleeding or cracked nipples during breastfeeding, leads to hemolysis and excess bilirubin production. The newborn's liver, still developing, may not clear this bilirubin quickly enough, resulting in jaundice.

Risk Factors

• Maternal vaginal bleeding during delivery or postpartum
• Breastfeeding with cracked or bleeding nipples
• Instrumental delivery (e.g., forceps, vacuum extraction) increasing maternal-fetal blood mixing
• Prematurity (reduced bilirubin clearance capacity)
• Large-for-gestational-age infants (higher bilirubin load)

Symptoms

• Yellowing of the skin and eyes (jaundice) appearing within the first few days of life
• Dark, tarry stools (melena) or pink-tinged urine
• Mild lethargy or poor feeding (if bilirubin levels are significantly elevated)
• No signs of maternal blood in the newborn's vomit or stool (distinguishes from other causes)

Diagnosis

Diagnosis involves assessing bilirubin levels (total and direct) and evaluating for hemolysis. A key step is confirming the presence of maternal blood, often via the Apt test (distinguishes maternal from newborn blood in stool). Clinical history, including maternal bleeding or breastfeeding issues, supports the diagnosis.

Treatment Options

Treatment focuses on managing bilirubin levels and addressing the underlying cause. Phototherapy may be used if bilirubin is elevated. For breastfeeding-related cases, maternal nipple care or temporary formula supplementation may be recommended. No specific treatment for the swallowed blood itself is needed, as it resolves as the source is addressed.

Prognosis and Follow-Up

Prognosis is generally excellent, as the condition is typically benign and resolves once the source of maternal blood is managed. Follow-up includes monitoring bilirubin levels until they normalize and ensuring the newborn feeds well. Most cases resolve within days to weeks without long-term effects.

Complications

Complications are rare but may include severe hyperbilirubinemia if bilirubin levels rise rapidly, potentially leading to bilirubin encephalopathy (kernicterus) if untreated. Early recognition and management minimize this risk.

Lifestyle & Prevention

Prevention involves addressing maternal bleeding sources (e.g., treating vaginal lacerations, managing cracked nipples) and ensuring proper breastfeeding techniques. For high-risk deliveries, careful monitoring of bilirubin levels in the first days of life is recommended.

When to Seek Professional Help

Seek medical attention if jaundice appears within the first 24 hours of life, bilirubin levels rise rapidly, or the newborn shows signs of lethargy, poor feeding, or irritability. Prompt evaluation is critical to rule out other causes and prevent complications.

Tips for Medical Coders

Document the presence of maternal blood (e.g., vaginal bleeding, breastfeeding issues) and confirm via testing (e.g., Apt test) when possible. Ensure the diagnosis aligns with clinical findings and exclude other causes of neonatal jaundice. Code P58.5 is specific to swallowed maternal blood and should not be used for other hemolytic or traumatic causes.